Insulin Sensitivity of the Brain in Pathogenesis of Diabetes Mellitus Type 2
Not Applicable
- Conditions
- Human Physiology of Energy Homeostasis
- Interventions
- Drug: Saline
- Registration Number
- NCT00638209
- Lead Sponsor
- University Hospital Tuebingen
- Brief Summary
The purpose of the study is to investigate whether insulin sensitivity of the human brain correlates with insulin sensitivity of the liver.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 42
Inclusion Criteria
- Age 18-70 Risk factor(s) for type 2 diabetes (e.g. overweight, family history of diabetes)
Exclusion Criteria
- Type 2 diabetes pregnancy acute or chronic diseases
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description I Human insulin - P Saline -
- Primary Outcome Measures
Name Time Method Insulin effect on cortical function (spectral analysis) 2 weeks
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link brain insulin sensitivity to hepatic insulin resistance in T2DM?
How does central insulin action compare to peripheral in regulating glucose homeostasis in NCT00638209?
What biomarkers correlate with brain insulin signaling efficacy in energy metabolism disorders?
Are there adverse events associated with intranasal insulin delivery for central metabolic regulation?
What combination therapies enhance brain insulin sensitivity in type 2 diabetes pathogenesis?
Trial Locations
- Locations (2)
University Hospital Tuebingen, Internal Medicine IV
🇩🇪Tuebingen, Germany
University Hospital Tuebingen
🇩🇪Tuebingen, Germany
University Hospital Tuebingen, Internal Medicine IV🇩🇪Tuebingen, Germany